Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4sc-202
1. 910462-43-0
2. 4sc-202
3. (e)-n-(2-aminophenyl)-3-(1-((4-(1-methyl-1h-pyrazol-4-yl)phenyl)sulfonyl)-1h-pyrrol-3-yl)acrylamide
4. 264arm7uxx
5. Hdac Inhibitor 4sc-202
6. 2-propenamide, N-(2-aminophenyl)-3-(1-((4-(1-methyl-1h-pyrazol-4-yl)phenyl)sulfonyl)-1h-pyrrol-3-yl)-, (2e)-
7. Domatinostatum
8. Refchem:920610
9. (2e)-n-(2-aminophenyl)-3-(1-(4-(1-methyl-1h-pyrazol-4-yl)benzenesulfonyl)-1h-pyrrol-3-yl)prop-2-enamide
10. 4sc-202 (free Base)
11. (e)-n-(2-aminophenyl)-3-[1-[4-(1-methylpyrazol-4-yl)phenyl]sulfonylpyrrol-3-yl]prop-2-enamide
12. Mfcd28155264
13. Unii-264arm7uxx
14. 4sc202
15. Domatinostat [inn]
16. Domatinostat (4sc-202)
17. Domatinostat [who-dd]
18. Orb1300834
19. Schembl1613939
20. Chembl4283683
21. Schembl30477018
22. Prxxymvlykjitb-izzdovswsa-n
23. Glxc-10802
24. Bcp18522
25. Bdbm50470579
26. Hy-16012a
27. S7555
28. Akos030526982
29. Ccg-269205
30. Cs-3275
31. Db13101
32. Ncgc00384199-04
33. 4sc-202?
34. As-77606
35. Bp-40062
36. Ns00072115
37. Brd-k11773281-001-01-2
38. Brd-k11773281-075-01-6
39. Brd-k11773281-075-02-4
40. Q27254045
41. (e)-n-(2-amino-phenyl)-3-{1-[4-(1-methyl-1h-pyrazol-4-yl)-benzene Sulfonyl]-1h-pyrrol-3-yl}-acrylamide
42. (e)-n-(2-amino-phenyl)-3-{1-[4-(1-methyl-1h-pyrazol-4-yl)-benzenesulfonyl]-1h-pyrrol-3-yl}-acrylamide
| Molecular Weight | 447.5 g/mol |
|---|---|
| Molecular Formula | C23H21N5O3S |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 120 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 775 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
39
PharmaCompass offers a list of Domatinostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Domatinostat manufacturer or Domatinostat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Domatinostat manufacturer or Domatinostat supplier.
A Domatinostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Domatinostat, including repackagers and relabelers. The FDA regulates Domatinostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Domatinostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Domatinostat supplier is an individual or a company that provides Domatinostat active pharmaceutical ingredient (API) or Domatinostat finished formulations upon request. The Domatinostat suppliers may include Domatinostat API manufacturers, exporters, distributors and traders.
Domatinostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Domatinostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Domatinostat GMP manufacturer or Domatinostat GMP API supplier for your needs.
A Domatinostat CoA (Certificate of Analysis) is a formal document that attests to Domatinostat's compliance with Domatinostat specifications and serves as a tool for batch-level quality control.
Domatinostat CoA mostly includes findings from lab analyses of a specific batch. For each Domatinostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Domatinostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Domatinostat EP), Domatinostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Domatinostat USP).
